Diltiazem Hydrochloride Tablet
FDA Label NDC 70771-1932

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Diltiazem Hydrochloride (NDC 70771-1932). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1929-1 in bottles of 100 tablets

Diltiazem hydrochloride tablets USP, 30 mg

100 Tablets

Rx Only

30 mg 100s Label (F63d2c9f F49a 4b36 B25d 6fbe3ab5577f 01)

NDC 70771-1930-1 in bottles of 100 tablets

Diltiazem hydrochloride tablets USP, 60 mg

100 Tablets

Rx Only

60 mg 100s (F63d2c9f F49a 4b36 B25d 6fbe3ab5577f 02)

NDC 70771-1931-1 in bottles of 100 tablets

Diltiazem hydrochloride tablets USP, 90 mg

100 Tablets

Rx Only

90 mg 100s (F63d2c9f F49a 4b36 B25d 6fbe3ab5577f 03)

NDC 70771-1932-1 in bottles of 100 tablets

Diltiazem hydrochloride tablets USP, 120 mg

100 Tablets

Rx Only

120 mg 100s (F63d2c9f F49a 4b36 B25d 6fbe3ab5577f 04)

* Please review the disclaimer below.